RTW Biotech Opportunities NAV Report for August Valued at $2.92 per Share
RTW Biotech Opportunities announced its NAV for August at $2.92 per share. This report has significant impacts on market...
RTW Biotech Opportunities announced its NAV for August at $2.92 per share. This report has significant impacts on market...
Greg Stanton, a member of the European Central Bank's board, pointed to the continued need for stricter monetary policie...
The Indian Quantum Data Energy power plant, with a production capacity of 160 megawatts, has been commissioned. This pro...
Legal & General has initiated the second phase of its share buyback program worth £600 million. This move follows a rece...
AstraZeneca's Etcamah trial failed to achieve its main objective, leading to a decline in the company's stock value.
Tesla continues to expand its operations in Asian markets by registering a new unit in Vietnam. This move aims to streng...
Oracle Power has successfully removed barriers related to the gold extraction project in Australia. This action could fa...
Asia Strategic Holdings has introduced its new auditor by selecting OneStop Assurance. This change is aimed at improving...
GSK has recently released positive data from the clinical trial of the Jideytro drug for lung cancer treatment. This adv...
Greg Stanton, CEO of Zscaler, pointed out the significant growth of AI-based cybersecurity and the increasing trend of z...
Trump and Xi have issued serious warnings in their recent statements regarding the threats posed by artificial intellige...
Greg Stanton, an official of the Bank of Japan, emphasized the necessity of paying attention to non-linear inflation jum...